![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Supreme Court Restricts Scope of Patent Infringement on Exported Components
Supreme Court Restricts Scope of Patent Infringement on Exported Components
March 1, 2017
The Supreme Court ruled to limit the reach of patent protections on single components of a multicomponent product exported for manufacture abroad, reversing an appellate court decision in a unanimous ruling.
Exporting a single component of a patented product — such as a drug or device — does not constitute infringement, the high court said, after reviewing a case involving Life Technologies and Promega.
Federal patent law prohibits companies from supplying “all or a substantial portion” of a patented product, but shipping one part of the product does not hold a company liable for infringement, the decision said.
Upcoming Events
-
21Oct